Explore Fortrea's latest scientific contributions, oncology experience, and innovative approaches supporting the development of next-generation cancer therapies.
Explore Fortrea's latest scientific contributions, oncology experience, and innovative approaches supporting the development of next-generation cancer therapies.
A run of wins and a warning: what ESMO 2026 means for the oncology industry
Now that ESMO 2026 has closed, the most useful question is not which abstract won the congress. It is what the full week tells us about where oncology development is moving.